Twist Bioscience: Nicolas Barthelemy
Twist Bioscience has appointed Nicolas Barthelemy to its board of directors. Barthelemy has more than 25 years of experience in the life science industry, the company said. Most recently, he served as president and CEO of privately held molecular diagnostics company Biotheranostics. He has also served as president of global commercial operations at Life Technologies (now Thermo Fisher Scientific), and has served in various operational and commercial roles, including as vice president of manufacturing for Biogen. He began his career with Merck as a project engineer in the vaccine division. Barthelemy currently also serves on the board of Repligen, Fluidigm, Biocare Medical, and 908 Devices.
Progenity: Sami Shihabi
Progenity promoted Sami Shihabi to chief commercial officer. In his new role, Shihabi will oversee the global commercial operations and corporate development strategies for Progenity’s women’s health and precision medicine business units. He will lead all commercial functional areas including sales, marketing, and managed care. Shihabi joined Progenity in 2018 as senior vice president of marketing and portfolio strategy. He previously was chief commercial officer at Prometheus Laboratories.
Myriad Genetics: Mark Pollack
Myriad Genetics has named Mark Pollack as chief medical officer of Myriad Neuroscience. Pollack will start in this new role on Jan. 15, 2020, and will report to Mark Verratti, president of the neuroscience division. In this position, Pollack will be in charge of efforts to integrate the GeneSight pharmacogenetic test into clinical practice. Pollack is a psychiatrist with three decades of experience in clinical psychiatry and neuroscience. He served as professor and chair of the psychiatry department at Rush University Medical Center in Chicaco, and before that he was a psychiatry professor at Harvard Medical School and directed the Center of Anxiety and Traumatic Stress Disorders at Massachusetts General Hospital.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.